Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain - PubMed (original) (raw)

Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

Emilio Pérez-Trallero et al. Antimicrob Agents Chemother. 2005 May.

Abstract

A multicenter susceptibility surveillance (the S.A.U.C.E. project) including 2,721 Streptococcus pneumoniae, 3,174 Streptococcus pyogenes, and 2,645 Haemophilus influenzae consecutive isolates was carried out in 25 hospitals all over Spain from November 2001 to October 2002 to evaluate the current epidemiology of resistance of the main bacteria involved in community-acquired respiratory tract infections. Susceptibility testing was performed in a single centralized laboratory by a broth microdilution method. The prevalence of resistant S. pneumoniae strains was 0.4% for cefotaxime, 4.4% for amoxicillin and amoxicillin-clavulanic acid, 25.6% for cefuroxime-axetil, 34.5% for erythromycin, clarithromycin, and azithromycin, and 36.0% for cefaclor. Phenotypes of resistance to erythromycin were MLS(B) (macrolide-lincosamide-streptogramin B) in 89.9% (gene ermB) and M (macrolide) in 9.7% of cases (gene mefA). No strain harbored both genes simultaneously. Serotypes 19, 6, 23, 14, and 3 were the most prevalent, accounting for 54.6% of the total isolates. Resistance to macrolides seems to be the most alarming point, since among penicillin-susceptible isolates it reached 15.1% compared to 55.8% among penicillin-resistant strains. Geographically, a number of regions had rates of erythromycin resistance above 40% (even higher in children). Resistance to erythromycin was also high in S. pyogenes isolates: mean regional 33.2%, beta-lactamase-producing H. influenzae were 20%, whereas 4.4% had a beta-lactamase-negative, ampicillin-resistant phenotype. We highlight the importance of different geographical frequencies of coresistance (associations of resistance to different drugs within the same species) and coupled resistance (association of resistance between different species) probably resulting from different local coselective events.

PubMed Disclaimer

Figures

FIG. 1.

Map of Spain and its autonomous communities. The number of isolates of the three species tested is also given.

FIG. 2.

Geographical selection of coresistance and coselection of resistance.

Cited by

Sheet, Surveillance, Strategy, Salvage and Shield in global biodefense system to protect the public health and tackle the incoming pandemics.
Wang X, Wu T, Oliveira LFS, Zhang D. Wang X, et al. Sci Total Environ. 2022 May 20;822:153469. doi: 10.1016/j.scitotenv.2022.153469. Epub 2022 Jan 29. Sci Total Environ. 2022. PMID: 35093353 Free PMC article. Review.
Tratamiento empírico de las infecciones en el adulto.
[No authors listed] [No authors listed] FMC. 2007;14:7-58. doi: 10.1016/S1134-2072(07)71960-6. Epub 2009 Jan 6. FMC. 2007. PMID: 32288493 Free PMC article. Spanish. No abstract available.
Infecciones por neumococo. Clasificación. Factores predisponentes. Aspectos patogénicos de relevancia clínica o diagnóstica. Manifestaciones clínicas. Formas de comienzo.
Serrano-Heranz R, Sicilia-Urbán JJ, Sanz-Rojas P. Serrano-Heranz R, et al. Medicine (Madr). 2010 Mar;10(50):3352-3359. doi: 10.1016/S0304-5412(10)70042-1. Epub 2010 Mar 20. Medicine (Madr). 2010. PMID: 32287886 Free PMC article. Spanish. No abstract available.
Case-based surveillance of antimicrobial resistance with full susceptibility profiles.
Ryu S, Cowling BJ, Wu P, Olesen S, Fraser C, Sun DS, Lipsitch M, Grad YH. Ryu S, et al. JAC Antimicrob Resist. 2019 Dec;1(3):dlz070. doi: 10.1093/jacamr/dlz070. Epub 2019 Dec 10. JAC Antimicrob Resist. 2019. PMID: 32280945 Free PMC article.
Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.
Giménez MJ, Aguilar L, Granizo JJ. Giménez MJ, et al. Multidiscip Respir Med. 2018 Nov 2;13:40. doi: 10.1186/s40248-018-0152-5. eCollection 2018. Multidiscip Respir Med. 2018. PMID: 30410757 Free PMC article. Review.

References

1. Aguilar, L., M. J. Gimenez, C. Garcia-Rey, and J. E. Martin. 2002. New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with beta-lactam antibiotics. J. Antimicrob. Chemother. Suppl. C:93-100. - PubMed
1. Block, S. L., J. Hedrick, C. J. Harrison, R. Tyler, A. Smith, R. Findlay, and E. Keegan. 2004. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J. 23:829-833. - PubMed
1. Casey, J. R., and M. E. Pichichero. 2004. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr. Infect. Dis. J. 23:824-828. - PubMed
1. Cornaglia, G., W. Hryniewicz, V. Jarlier, G. Kahlmeter, H. Mittermayer, L. Stratchounski, and F. Baquero. 2004. European recommendations for antimicrobial resistance surveillance. Clin. Microbiol. Infect. 10:349-383. - PubMed
1. File, T. M., M. R. Jacobs, M. D. Poole, and B. Wynne. 2002. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate. Int. J. Antimicrob. Agents. 20:235. - PubMed

Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain - PubMed (original) (raw)